Copyright Reports & Markets. All rights reserved.

Global Eszopiclone Drug Market Growth (Status and Outlook) 2019-2024

Request for Sample of this report
Buy now

Table of Contents

    2019-2024 Global Eszopiclone Drug Market Report (Status and Outlook)

      1 Scope of the Report

      • 1.1 Market Introduction
      • 1.2 Research Objectives
      • 1.3 Years Considered
      • 1.4 Market Research Methodology
      • 1.5 Economic Indicators
      • 1.6 Currency Considered

      2 Executive Summary

      • 2.1 World Market Overview
        • 2.1.1 Global Eszopiclone Drug Market Size 2014-2024
        • 2.1.2 Eszopiclone Drug Market Size CAGR by Region
      • 2.2 Eszopiclone Drug Segment by Type
        • 2.2.1 1 mg Tablets
        • 2.2.2 2 mg Tablets
        • 2.2.3 3 mg Tablets
      • 2.3 Eszopiclone Drug Market Size by Type
        • 2.3.1 Global Eszopiclone Drug Market Size Market Share by Type (2014-2019)
        • 2.3.2 Global Eszopiclone Drug Market Size Growth Rate by Type (2014-2019)
      • 2.4 Eszopiclone Drug Segment by Application
        • 2.4.1 Hospital
        • 2.4.2 Drug store
      • 2.5 Eszopiclone Drug Market Size by Application
        • 2.5.1 Global Eszopiclone Drug Market Size Market Share by Application (2014-2019)
        • 2.5.2 Global Eszopiclone Drug Market Size Growth Rate by Application (2014-2019)

      3 Global Eszopiclone Drug by Players

      • 3.1 Global Eszopiclone Drug Market Size Market Share by Players
        • 3.1.1 Global Eszopiclone Drug Market Size by Players (2017-2019)
        • 3.1.2 Global Eszopiclone Drug Market Size Market Share by Players (2017-2019)
      • 3.2 Global Eszopiclone Drug Key Players Head office and Products Offered
      • 3.3 Market Concentration Rate Analysis
        • 3.3.1 Competition Landscape Analysis
        • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
      • 3.4 New Products and Potential Entrants
      • 3.5 Mergers & Acquisitions, Expansion

      4 Eszopiclone Drug by Regions

      • 4.1 Eszopiclone Drug Market Size by Regions
      • 4.2 Americas Eszopiclone Drug Market Size Growth
      • 4.3 APAC Eszopiclone Drug Market Size Growth
      • 4.4 Europe Eszopiclone Drug Market Size Growth
      • 4.5 Middle East & Africa Eszopiclone Drug Market Size Growth

      5 Americas

      • 5.1 Americas Eszopiclone Drug Market Size by Countries
      • 5.2 Americas Eszopiclone Drug Market Size by Type
      • 5.3 Americas Eszopiclone Drug Market Size by Application
      • 5.4 United States
      • 5.5 Canada
      • 5.6 Mexico
      • 5.7 Key Economic Indicators of Few Americas Countries

      6 APAC

      • 6.1 APAC Eszopiclone Drug Market Size by Countries
      • 6.2 APAC Eszopiclone Drug Market Size by Type
      • 6.3 APAC Eszopiclone Drug Market Size by Application
      • 6.4 China
      • 6.5 Japan
      • 6.6 Korea
      • 6.7 Southeast Asia
      • 6.8 India
      • 6.9 Australia
      • 6.10 Key Economic Indicators of Few APAC Countries

      7 Europe

      • 7.1 Europe Eszopiclone Drug by Countries
      • 7.2 Europe Eszopiclone Drug Market Size by Type
      • 7.3 Europe Eszopiclone Drug Market Size by Application
      • 7.4 Germany
      • 7.5 France
      • 7.6 UK
      • 7.7 Italy
      • 7.8 Russia
      • 7.9 Spain
      • 7.10 Key Economic Indicators of Few Europe Countries

      8 Middle East & Africa

      • 8.1 Middle East & Africa Eszopiclone Drug by Countries
      • 8.2 Middle East & Africa Eszopiclone Drug Market Size by Type
      • 8.3 Middle East & Africa Eszopiclone Drug Market Size by Application
      • 8.4 Egypt
      • 8.5 South Africa
      • 8.6 Israel
      • 8.7 Turkey
      • 8.8 GCC Countries

      9 Market Drivers, Challenges and Trends

      • 9.1 Market Drivers and Impact
        • 9.1.1 Growing Demand from Key Regions
        • 9.1.2 Growing Demand from Key Applications and Potential Industries
      • 9.2 Market Challenges and Impact
      • 9.3 Market Trends

      10 Global Eszopiclone Drug Market Forecast

      • 10.1 Global Eszopiclone Drug Market Size Forecast (2019-2024)
      • 10.2 Global Eszopiclone Drug Forecast by Regions
        • 10.2.1 Global Eszopiclone Drug Forecast by Regions (2019-2024)
        • 10.2.2 Americas Market Forecast
        • 10.2.3 APAC Market Forecast
        • 10.2.4 Europe Market Forecast
        • 10.2.5 Middle East & Africa Market Forecast
      • 10.3 Americas Forecast by Countries
        • 10.3.1 United States Market Forecast
        • 10.3.2 Canada Market Forecast
        • 10.3.3 Mexico Market Forecast
        • 10.3.4 Brazil Market Forecast
      • 10.4 APAC Forecast by Countries
        • 10.4.1 China Market Forecast
        • 10.4.2 Japan Market Forecast
        • 10.4.3 Korea Market Forecast
        • 10.4.4 Southeast Asia Market Forecast
        • 10.4.5 India Market Forecast
        • 10.4.6 Australia Market Forecast
      • 10.5 Europe Forecast by Countries
        • 10.5.1 Germany Market Forecast
        • 10.5.2 France Market Forecast
        • 10.5.3 UK Market Forecast
        • 10.5.4 Italy Market Forecast
        • 10.5.5 Russia Market Forecast
        • 10.5.6 Spain Market Forecast
      • 10.6 Middle East & Africa Forecast by Countries
        • 10.6.1 Egypt Market Forecast
        • 10.6.2 South Africa Market Forecast
        • 10.6.3 Israel Market Forecast
        • 10.6.4 Turkey Market Forecast
        • 10.6.5 GCC Countries Market Forecast
      • 10.7 Global Eszopiclone Drug Forecast by Type
      • 10.8 Global Eszopiclone Drug Forecast by Application

      11 Key Players Analysis

      • 11.1 Sunovion
        • 11.1.1 Company Details
        • 11.1.2 Eszopiclone Drug Product Offered
        • 11.1.3 Sunovion Eszopiclone Drug Revenue, Gross Margin and Market Share (2017-2019)
        • 11.1.4 Main Business Overview
        • 11.1.5 Sunovion News
      • 11.2 Teva
        • 11.2.1 Company Details
        • 11.2.2 Eszopiclone Drug Product Offered
        • 11.2.3 Teva Eszopiclone Drug Revenue, Gross Margin and Market Share (2017-2019)
        • 11.2.4 Main Business Overview
        • 11.2.5 Teva News
      • 11.3 Dr. Reddy's Laboratories
        • 11.3.1 Company Details
        • 11.3.2 Eszopiclone Drug Product Offered
        • 11.3.3 Dr. Reddy's Laboratories Eszopiclone Drug Revenue, Gross Margin and Market Share (2017-2019)
        • 11.3.4 Main Business Overview
        • 11.3.5 Dr. Reddy's Laboratories News
      • 11.4 Sun Pharmaceutical
        • 11.4.1 Company Details
        • 11.4.2 Eszopiclone Drug Product Offered
        • 11.4.3 Sun Pharmaceutical Eszopiclone Drug Revenue, Gross Margin and Market Share (2017-2019)
        • 11.4.4 Main Business Overview
        • 11.4.5 Sun Pharmaceutical News
      • 11.5 Glenmark Pharmaceuticals
        • 11.5.1 Company Details
        • 11.5.2 Eszopiclone Drug Product Offered
        • 11.5.3 Glenmark Pharmaceuticals Eszopiclone Drug Revenue, Gross Margin and Market Share (2017-2019)
        • 11.5.4 Main Business Overview
        • 11.5.5 Glenmark Pharmaceuticals News
      • 11.6 Aurobindo Pharma
        • 11.6.1 Company Details
        • 11.6.2 Eszopiclone Drug Product Offered
        • 11.6.3 Aurobindo Pharma Eszopiclone Drug Revenue, Gross Margin and Market Share (2017-2019)
        • 11.6.4 Main Business Overview
        • 11.6.5 Aurobindo Pharma News
      • 11.7 Lupin Pharmaceuticals
        • 11.7.1 Company Details
        • 11.7.2 Eszopiclone Drug Product Offered
        • 11.7.3 Lupin Pharmaceuticals Eszopiclone Drug Revenue, Gross Margin and Market Share (2017-2019)
        • 11.7.4 Main Business Overview
        • 11.7.5 Lupin Pharmaceuticals News
      • 11.8 Mylan
        • 11.8.1 Company Details
        • 11.8.2 Eszopiclone Drug Product Offered
        • 11.8.3 Mylan Eszopiclone Drug Revenue, Gross Margin and Market Share (2017-2019)
        • 11.8.4 Main Business Overview
        • 11.8.5 Mylan News
      • 11.9 West Ward Pharmaceuticals
        • 11.9.1 Company Details
        • 11.9.2 Eszopiclone Drug Product Offered
        • 11.9.3 West Ward Pharmaceuticals Eszopiclone Drug Revenue, Gross Margin and Market Share (2017-2019)
        • 11.9.4 Main Business Overview
        • 11.9.5 West Ward Pharmaceuticals News

      12 Research Findings and Conclusion

      Eszopiclone, marketed by Sunovion under the brand-name Lunesta, is a nonbenzodiazepine hypnotic agent used in the treatment of insomnia.

      According to this study, over the next five years the Eszopiclone Drug market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Eszopiclone Drug business, shared in Chapter 3.

      This report presents a comprehensive overview, market shares and growth opportunities of Eszopiclone Drug market by product type, application, key companies and key regions.

      This study considers the Eszopiclone Drug value generated from the sales of the following segments:

      Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
      1 mg Tablets
      2 mg Tablets
      Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
      Hospital
      Drug store

      This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
      Americas
      United States
      Canada
      Mexico
      Brazil
      APAC
      China
      Japan
      Korea
      Southeast Asia
      India
      Australia
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Middle East & Africa
      Egypt
      South Africa
      Israel
      Turkey
      GCC Countries

      The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
      Sunovion
      Teva
      Dr. Reddy's Laboratories
      Sun Pharmaceutical
      Glenmark Pharmaceuticals
      Aurobindo Pharma
      Lupin Pharmaceuticals
      Mylan
      West Ward Pharmaceuticals

      In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

      Research objectives
      To study and analyze the global Eszopiclone Drug market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
      To understand the structure of Eszopiclone Drug market by identifying its various subsegments.
      Focuses on the key global Eszopiclone Drug players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
      To analyze the Eszopiclone Drug with respect to individual growth trends, future prospects, and their contribution to the total market.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      To project the size of Eszopiclone Drug submarkets, with respect to key regions (along with their respective key countries).
      To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
      To strategically profile the key players and comprehensively analyze their growth strategies.

      Buy now